| Product NDC: | 63323-344 |
| Proprietary Name: | Ceftriaxone |
| Non Proprietary Name: | CEFTRIAXONE SODIUM |
| Active Ingredient(s): | 250 mg/1 & nbsp; CEFTRIAXONE SODIUM |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-344 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065245 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060308 |
| Package NDC: | 63323-344-10 |
| Package Description: | 25 VIAL in 1 TRAY (63323-344-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| NDC Code | 63323-344-10 |
| Proprietary Name | Ceftriaxone |
| Package Description | 25 VIAL in 1 TRAY (63323-344-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 63323-344 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CEFTRIAXONE SODIUM |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20060308 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CEFTRIAXONE SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |